Company Filing History:
Years Active: 2014-2018
Title: Innovations in Cancer Treatment by Mika K Derynck
Introduction
Mika K Derynck is a notable inventor based in San Mateo, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods for treating breast cancer, Derynck has been instrumental in developing therapies that improve patient outcomes.
Latest Patents
Derynck holds two patents that highlight his expertise in oncology. The first patent involves methods of treating PR-positive, luminal A breast cancer using the PI3K inhibitor, pictilisib. This patent outlines methods and compositions for treating breast cancer patients with pictilisib in combination with an endocrine therapy agent. The second patent focuses on extending the time to disease progression or survival in cancer patients. This application describes a treatment approach for patients with HER activation by utilizing a HER dimerization inhibitor, such as pertuzumab.
Career Highlights
Mika K Derynck is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
Derynck has worked alongside notable colleagues, including Stephen M Kelsey and Lori Friedman, who have also made significant contributions to cancer research. Their collaborative efforts have further advanced the understanding and treatment of various cancer types.
Conclusion
Mika K Derynck's innovative work in cancer treatment exemplifies the impact of research and development in improving patient care. His patents and collaborations reflect a commitment to advancing medical science and enhancing the lives of those affected by cancer.